Opaleye Management reports $31,687 Grace Therapeutics common share purchase
Opaleye Management raised its stake in Grace Therapeutics to 2,855,318 shares, held indirectly through Opaleye, L.P. The fund bought 15,089 shares at USD 2.1 each in open-market purchases. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives